High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular responses
Sulaimon Akanmu, Bobby Brooke Herrera, Beth Chaplin, Sade Ogunsola, Akin Osibogun, Fatima Onawoga, Sarah John-Olabode, Iorhen E. Akase, Augustina Nwosu, Donald J Hamel, Charlotte A Chang, View ORCID ProfilePhyllis J Kanki
doi: https://doi.org/10.1101/2022.11.30.22282833
Sulaimon Akanmu
1Lagos University Teaching Hospital, College of Medicine, University of Lagos, Lagos, Nigeria
Bobby Brooke Herrera
2Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA
3Department of Medicine, Division of Allergy, Immunology, and Infectious Diseases, and Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA
4Rutgers Global Health Institute, Rutgers University, New Brunswick, NJ, USA
5Mir Biosciences, Inc., Boston, MA, USA
Beth Chaplin
2Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Sade Ogunsola
1Lagos University Teaching Hospital, College of Medicine, University of Lagos, Lagos, Nigeria
Akin Osibogun
1Lagos University Teaching Hospital, College of Medicine, University of Lagos, Lagos, Nigeria
6Lagos State COVID-19 Taskforce, Lagos State Ministry of Health, Lagos, Nigeria
Fatima Onawoga
1Lagos University Teaching Hospital, College of Medicine, University of Lagos, Lagos, Nigeria
Sarah John-Olabode
1Lagos University Teaching Hospital, College of Medicine, University of Lagos, Lagos, Nigeria
Iorhen E. Akase
1Lagos University Teaching Hospital, College of Medicine, University of Lagos, Lagos, Nigeria
Augustina Nwosu
1Lagos University Teaching Hospital, College of Medicine, University of Lagos, Lagos, Nigeria
Donald J Hamel
2Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Charlotte A Chang
2Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Phyllis J Kanki
2Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Data Availability
All data produced in the present study are available upon reasonable request to the corresponding author.
Posted December 01, 2022.
High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular responses
Sulaimon Akanmu, Bobby Brooke Herrera, Beth Chaplin, Sade Ogunsola, Akin Osibogun, Fatima Onawoga, Sarah John-Olabode, Iorhen E. Akase, Augustina Nwosu, Donald J Hamel, Charlotte A Chang, Phyllis J Kanki
medRxiv 2022.11.30.22282833; doi: https://doi.org/10.1101/2022.11.30.22282833
High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular responses
Sulaimon Akanmu, Bobby Brooke Herrera, Beth Chaplin, Sade Ogunsola, Akin Osibogun, Fatima Onawoga, Sarah John-Olabode, Iorhen E. Akase, Augustina Nwosu, Donald J Hamel, Charlotte A Chang, Phyllis J Kanki
medRxiv 2022.11.30.22282833; doi: https://doi.org/10.1101/2022.11.30.22282833
Subject Area
Subject Areas
- Addiction Medicine (369)
- Allergy and Immunology (689)
- Anesthesia (184)
- Cardiovascular Medicine (2748)
- Dermatology (235)
- Emergency Medicine (414)
- Epidemiology (12398)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4259)
- Geriatric Medicine (396)
- Health Economics (699)
- Health Informatics (2756)
- Health Policy (1018)
- Hematology (369)
- HIV/AIDS (879)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (453)
- Neurology (4036)
- Nursing (216)
- Nutrition (598)
- Oncology (2126)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (312)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1148)
- Primary Care Research (468)
- Public and Global Health (6652)
- Radiology and Imaging (1446)
- Respiratory Medicine (886)
- Rheumatology (421)
- Sports Medicine (353)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)